Positive Proof of Concept for NutriLeads Key Ingredient

53a38dad-9600-4b5d-b8ca-7a91174f66b9articleimage.jpg

02 Jan 2016 --- Nutrition and health start-up NutriLeads is celebrating the beginning of 2017 following the positive findings of a proof of concept study for humans in connection with the lead ingredient Immuno Modulatory Plant Polysaccharide-1(IMPP-1). 

Clinical research company analyze & realize GmbH, the partner in the clinical study, says IMPP-1  is safe, well tolerated and supports immune function in humans.

NutriLeads develops nutritional ingredients for application in health-promoting food products. Initially founded in 2012 based upon an invention originating from Unilever, NutriLeads closed a successful seed financing round with an investor syndicate comprising Thuja Capital, DSM Venturing BV, PPM Oost and Shift Invest in 2015 and is currently discussing a series A financing.

As a clinical research organization and consulting firm specialized in natural health products, analyze & realize GmbH was the selected partner to conduct the clinical study at its own study center in Berlin. In an overall project duration of one year, a&r’s R&D clinical department investigated IMPP-1 in healthy humans and proved with success the concept of the natural ingredient being supportive of immune function in humans.

NutriLeads is developing this patented ingredient for different food applications including dietary supplements, medical food and functional food to reach various target populations. 

IMPP-1 can be sustainably sourced from food crops.
 
The results of the first proof of concept study with IMPP-1 in healthy volunteers were evaluated by an international group of key opinion leaders from industry and academia. The experts concluded that the results demonstrate excellent tolerability and safety characteristics and significant and dose dependent stimulation of the immune system.
 
“The positive result in first proof of concept study in healthy volunteers provides the necessary confidence to go full speed ahead with our ambitious development program including several clinical trials to support the use of this proprietary ingredient from sustainable sources as dietary supplement and for application in specialized functional and medical food products”, says Ruud Albers, PhD, CEO of NutriLeads.
 
NutriLeads, as consortium leader, and four European partners – including a&r – have been awarded a €2 million Eurostars project called NIMF. 

The consortium will develop NutriLeads’ proprietary ingredient IMPP-1 into a new ingredient for medical food products to fight impaired immune function as a result of malnutrition (particularly common in a variety of patient groups).

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Microbiome solutions: A key theme at Vitafoods Europe 2018

24 May 2018 --- Research into the microbiome – the aggregated microbial species in our body – is gaining increasing attention and investment. Although the term is often associated with digestive health, the body, in fact, contains multiple microbiome. This is currently spurring on research and innovation in areas as wide-ranging as women’s health, weight management, immunity and skin health. At Vitafoods Europe 2018, NutritionInsight spoke with suppliers about their efforts and innovations in the microbiome space, using pre or probiotics for gut health and beyond.

Nutrition & Health News

Athletic endurance improved with Beneo's low glycemic carb, study finds

24 May 2018 --- Athletes who consumed a drink containing the functional carbohydrate, Palatinose, before exercise exhibited improved cycling performance, a study at the University of Freiburg has found. This was in comparison with participants who were given maltodextrin, a high glycemic carbohydrate, before exercising. The study's findings could hold potential for the use of Palatinose as a sports nutrition ingredient.

Nutrition & Health News

Nutrient breakthrough: Scientists show plants can be a dietary source of vitamin B12

24 May 2018 --- Scientists at the University of Kent have made a significant discovery about how the vitamin B12 content of some plants can be improved to make vegetarian and vegan diets more complete. Vitamin B12 (known as cobalamin) is an essential dietary component but vegans and vegetarians are more prone to B12 deficiency as plants neither make nor require this nutrient.

Nutrition & Health News

Green protein boost: INCJ and Mitsubishi Corp. invest over US$15m in microalgae protein maker

23 May 2018 --- Innovation Network Corporation of Japan (INCJ) and Mitsubishi Corp. (MC) have announced a joint investment in microalgae company Tavelmout through the acceptance of a third-party allocation of shares by Tavelmout. The total investment amounts to 1.7 billion yen (US$15.47 million), evenly split between INCJ and MC. Through their participation in Tavelmout, a company aiming to mass produce and popularize spirulina, MC and INCJ are seeking to contribute to the diversification of sustainable protein sources.

Nutrition & Health News

Diabetes UK: “Consumers want to see clearer calorie labeling on food and menus” 

23 May 2018 --- Consumers are more likely to purchase food if it is accompanied by clear calorie labels on its packaging or on the menu of the establishment, a survey conducted by Diabetes UK’s campaign, Food Upfront, has found. The survey sheds light on how the availability of clear labeling on food and drink could have considerable influence on the spending habits of the British public. Therefore, the campaign is calling for mandatory front-of-pack traffic light labeling on foods and menu calorie labeling in eating establishments.

More Articles
URL : http://www.nutritioninsight.com:80/news/positive-proof-of-concept-for-nutrileads-key-ingredient.html